Ir al contenido principal
  • Iniciar sesión
    Bienvenido.
    Mi cuenta
    Cierre de sesión

1ST SOURCE CORP (SRCE) Previsión de existencias 2025 - Predicción y análisis del precio de la IA

1ST SOURCE CORP (SRCE) Previsión del precio de las acciones de AI y análisis de inversiones

1ST SOURCE CORP Gráfico de cotizaciones y análisis técnico

Loading 1ST SOURCE CORP gráfico interactivo de cotizaciones y análisis técnico...

1ST SOURCE CORP (SRCE) - Análisis exhaustivo de valores e investigación de inversiones

Deep dive into 1ST SOURCE CORP's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about 1ST SOURCE CORP, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

Para 1ST SOURCE CORP: 1ST SOURCE CORP operates in the Finance sector, making it an emerging small-cap investment.

1ST SOURCE CORP (Símbolo bursátil: SRCE) es una empresa líder en el sector Finance. que opera específicamente en la industria State Commercial Banks..

La organización emplea a unos 1094 profesionales en todo el mundo .

La empresa se ha consolidado como una oportunidad de inversión emergente con un gran potencial de crecimiento.

Understanding Financial Performance

Qué significan estas métricas: Key financial indicators showing 1ST SOURCE CORP's revenue scale, profitability, market value, and shareholder returns.

Cómo leerlos: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

Para 1ST SOURCE CORP: With $391M in annual revenue and 34,8% net margin, the company demonstrates exceptional profitability.

Ingresos anuales: $391 millones generar un 34,8% margen de beneficio neto .

Capitalización bursátil: $1631 millones - Clasificado como inversión en pequeña capitalización con alto potencial de crecimiento.

Rentabilidad de los fondos propios (ROE): 13,3% - Por encima de la media eficiencia de la rentabilidad para el accionista, lo que indica áreas de mejora operativa.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for 1ST SOURCE CORP stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

Para 1ST SOURCE CORP: Unlock premium access to view detailed AI predictions and price targets.

🚀 Desbloquea las predicciones de IA Premium para acceder a nuestras previsiones avanzadas de aprendizaje automático para la acción 1ST SOURCE CORP, incluidos objetivos de precio a 7, 30 y 90 días con intervalos de confianza y evaluaciones de riesgo.

Understanding Market Position

What this analysis covers: 1ST SOURCE CORP's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

Para 1ST SOURCE CORP: Strong free cash flow generation demonstrates solid operational efficiency.

1ST SOURCE CORP compite estratégicamente en el altamente dinámico State Commercial Banks mercado, representa una inversión emergente de pequeña capitalización con un potencial de crecimiento sustancial y capacidad de disrupción del mercado .

La empresa demuestra una sólida eficiencia operativa a través de una fuerte generación de flujo de caja libre de $163 millones anualescomplementado por un impresionante crecimiento interanual del flujo de caja..

1ST SOURCE CORP (SRCE) Análisis fundamental y datos sobre operaciones con información privilegiada (Informes financieros trimestrales)

Datos financieros trimestrales completos, tendencias de beneficios, transacciones con información privilegiada y participaciones institucionales de 1ST SOURCE CORP análisis de valores.

Cargando 1ST SOURCE CORP análisis fundamental exhaustivo y datos de información privilegiada...

Profundice en la salud financiera, las métricas de valoración y la eficiencia operativa de 1ST SOURCE CORP para tomar decisiones de inversión informadas.

Comprender las métricas de valoración

Qué significan estas métricas: Las métricas de valoración ayudan a determinar si las acciones 1ST SOURCE CORP tienen un precio justo en comparación con sus beneficios, activos y posición en el mercado.

Cómo leerlos: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

Para 1ST SOURCE CORP: Con un PER de 11,55, el mercado ve las acciones potencialmente infravaloradas.

P/E Ratio 11,55x
P/B Ratio 1,36x
Market Cap $1631M
Dividend Yield 2,31%
EPS $5,70
Valor contable/acción $46,54
Ingresos/Acciones $15,20
FCF/Acción $5,72
Entender las métricas de rentabilidad

Qué significan estas métricas: Estos ratios miden la eficacia con la que 1ST SOURCE CORP convierte los ingresos en beneficios y genera rentabilidad para los accionistas.

Cómo leerlos: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

Para 1ST SOURCE CORP: Un ROE de 13,3% muestra bien creación de valor para el accionista.

ROE 13,3%
ROA 1,5%
Net Margin 34,8%
EBT Margin 45,6%
Tax Rate 23,1%
Entender las métricas de salud financiera

Qué significan estas métricas: Estos ratios evalúan la capacidad de 1ST SOURCE CORP para hacer frente a las obligaciones a corto plazo y gestionar eficazmente los niveles de endeudamiento.

Cómo leerlos: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

Para 1ST SOURCE CORP:

D/E Ratio 0,15x
Financial Leverage 9,26x
Entender las métricas del flujo de caja

Qué significan estas métricas: Las métricas de flujo de caja revelan la capacidad de 1ST SOURCE CORP para generar efectivo a partir de operaciones y financiar iniciativas de crecimiento.

Cómo leerlos: El flujo de caja operativo positivo es crucial. El flujo de caja libre muestra el dinero disponible para dividendos, recompras o inversiones.

Para 1ST SOURCE CORP: Flujo de caja libre de $163M proporciona flexibilidad para el rendimiento de los accionistas y las inversiones de crecimiento.

Operating Cash Flow $166M
Free Cash Flow $163M
Capital Spending $-3M
OCF Growth YoY -6,1%
FCF Growth YoY -1,6%
FCF/Sales 48,6%
CapEx/Sales 0,8%
Entender las métricas de eficiencia operativa

Qué significan estas métricas: Estos ratios miden la eficacia con la que 1ST SOURCE CORP utiliza sus activos y gestiona el capital circulante.

Cómo leerlos: Unos índices de rotación más elevados indican una utilización eficaz de los activos. Los periodos de cobro más cortos muestran una gestión eficaz del crédito.

Para 1ST SOURCE CORP: Una rotación de activos de 0,04x sugiere un margen de mejora en utilización de activos.

Asset Turnover 0,04x
Fixed Assets Turnover 2,8x
Comprender los datos de los estados financieros

Qué significan estas métricas: Cifras clave de la cuenta de resultados y el balance de 1ST SOURCE CORP que muestran los resultados financieros absolutos.

Cómo leerlos: Los ingresos muestran la escala empresarial, mientras que los márgenes indican la rentabilidad. Las partidas del balance revelan la estructura financiera.

Para 1ST SOURCE CORP: Con unos ingresos anuales de 391M, 1ST SOURCE CORP demuestra un tamaño empresarial sólido.

Cuenta de resultados ($ Millones)
Ingresos totales $391M
Gastos de venta, generales y administrativos $37M
Hechos destacados del balance (% Of Assets)
Cash & Short-term Investments 24%
Total Liabilities 89%
Short-term Debt 0%
Accounts Receivable 0%
Información sobre dividendos y accionistas
Dividends Per Share $1,46
Payout Ratio 0,3%
Shares Outstanding 26M
Métricas de crecimiento (interanual)
EPS Growth 8,4%

Última 1ST SOURCE CORP Noticias y análisis bursátiles

Noticias de última hora, informes de analistas y actualizaciones del mercado que afectan a la cotización de 1ST SOURCE CORP (SRCE) y a las perspectivas de inversión.

, fuente: Seeking Alpha

South Bend, Indiana--(Newsfile Corp. - July 24, 2025) - 1st Source Corporation (SRCE) announced today that after 50 years in successive leadership as President, Chairman and/or CEO of the corporation ...

, fuente: None

Source (SRCE) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the ...

, fuente: The Times of Northwest Indiana

1st Source Corporation, the parent company of 1st Source Bank, promoted Andrea Short to CEO as part of a succession plan. Short is already CEO of 1st Source Bank, the largest bank headquartered in ...

, fuente: The Times of Northwest Indiana

South Bend-based 1st Source Corp. is reporting third quarter net income of $13 million, up from $11.5 million during the same period last year. Chairman Christopher Murphy III says growth in loans and ...

1ST SOURCE CORP Competidores y análisis de pares - Finance Sector

Análisis comparativo de 1ST SOURCE CORP frente a sus homólogos y competidores del sector Finance, con previsiones basadas en IA y métricas financieras clave.

Empresa Código bursátil Previsión de IA a 90 días Capitalización bursátil (M USD) Ratio PER Ratio P/B
ABCB Unlock Forecast - 30 Days FREE Trial $5126M 13,1x 1,3x
ACNB Unlock Forecast - 30 Days FREE Trial $471M 18,7x 1,2x
ALLY Unlock Forecast - 30 Days FREE Trial $12250M 15,3x 0,9x
AMAL Unlock Forecast - 30 Days FREE Trial $1010M 10,8x 1,3x
ASB Unlock Forecast - 30 Days FREE Trial $4371M 31,4x 0,9x
ASBA Unlock Forecast - 30 Days FREE Trial $4154M 29,8x 0,9x
ASB-PE Unlock Forecast - 30 Days FREE Trial $3661M 26,3x 0,8x
ASB-PF Unlock Forecast - 30 Days FREE Trial $3552M 25,5x 0,7x
AUB Unlock Forecast - 30 Days FREE Trial $5019M 24,6x 1,0x
AUBN Unlock Forecast - 30 Days FREE Trial $77M 12,6x 1,1x
AUB-PA Unlock Forecast - 30 Days FREE Trial $3541M 17,4x 0,7x
BAFN Unlock Forecast - 30 Days FREE Trial $37M 4,0x 0,3x
BANR Unlock Forecast - 30 Days FREE Trial $2299M 12,6x 1,2x
BCML Unlock Forecast - 30 Days FREE Trial $331M 13,7x 1,0x
BFST Unlock Forecast - 30 Days FREE Trial $745M 9,7x 0,9x
BHB Unlock Forecast - 30 Days FREE Trial $493M 12,5x 1,1x
BK Unlock Forecast - 30 Days FREE Trial $78106M 15,7x 1,8x
BK-PK Unlock Forecast - 30 Days FREE Trial $18624M 3,7x 0,4x
BKSC Unlock Forecast - 30 Days FREE Trial $87M 13,4x 2,1x
BMRC Unlock Forecast - 30 Days FREE Trial $400M 57,8x 0,9x
BMTX Unlock Forecast - 30 Days FREE Trial $58M -4,5x 2,7x
BOH Unlock Forecast - 30 Days FREE Trial $2713M 15,9x 1,6x
BOH-PA Unlock Forecast - 30 Days FREE Trial $699M 4,1x 0,4x
BOH-PB Unlock Forecast - 30 Days FREE Trial $1070M 6,3x 0,6x
BOTJ Unlock Forecast - 30 Days FREE Trial $70M 9,8x 1,0x
BPOP Unlock Forecast - 30 Days FREE Trial $8481M 11,8x 1,4x
BPOPM Unlock Forecast - 30 Days FREE Trial $1734M 2,4x 0,3x
BPOPO Unlock Forecast - 30 Days FREE Trial $1712M 2,4x 0,3x
BPRN Unlock Forecast - 30 Days FREE Trial $225M 32,9x 0,9x
BRBS Unlock Forecast - 30 Days FREE Trial $358M -1,3x 1,0x
BSRR Unlock Forecast - 30 Days FREE Trial $417M 10,3x 1,2x
BSVN Unlock Forecast - 30 Days FREE Trial $466M 10,5x 2,0x
BUSE Unlock Forecast - 30 Days FREE Trial $2194M 13,3x 1,0x
BWB Unlock Forecast - 30 Days FREE Trial $451M 11,9x 1,0x
BWBBP Unlock Forecast - 30 Days FREE Trial $549M 14,5x 1,2x
BWFG Unlock Forecast - 30 Days FREE Trial $339M 16,3x 1,2x
BY Unlock Forecast - 30 Days FREE Trial $1332M 11,2x 1,1x
CATY Unlock Forecast - 30 Days FREE Trial $3460M 11,7x 1,2x
CBAN Unlock Forecast - 30 Days FREE Trial $299M 10,8x 1,0x
CBFV Unlock Forecast - 30 Days FREE Trial $177M 15,2x 1,2x
CBSH Unlock Forecast - 30 Days FREE Trial $7525M 15,4x 3,1x
CCB Unlock Forecast - 30 Days FREE Trial $1664M 35,0x 3,6x
CCBG Unlock Forecast - 30 Days FREE Trial $742M 12,8x 1,4x
CCFN Unlock Forecast - 30 Days FREE Trial $175M 8,6x 1,0x
CCNE Unlock Forecast - 30 Days FREE Trial $540M 9,9x 0,9x
CCNEP Unlock Forecast - 30 Days FREE Trial $523M 9,6x 0,8x
CFB Unlock Forecast - 30 Days FREE Trial $0M 12,2x 0,0x
CFFI Unlock Forecast - 30 Days FREE Trial $231M 9,5x 1,0x
CFG Unlock Forecast - 30 Days FREE Trial $22767M 14,3x 0,9x
CFG-PE Unlock Forecast - 30 Days FREE Trial $8985M 5,6x 0,4x
CFG-PH Unlock Forecast - 30 Days FREE Trial $11779M 7,4x 0,5x
CHMG Unlock Forecast - 30 Days FREE Trial $251M 22,4x 1,1x
CIVB Unlock Forecast - 30 Days FREE Trial $0M 10,8x 0,0x
CNOB Unlock Forecast - 30 Days FREE Trial $1262M 33,7x 0,8x
CNOBP Unlock Forecast - 30 Days FREE Trial $1181M 31,5x 0,8x
COFS Unlock Forecast - 30 Days FREE Trial $462M 32,7x 1,1x
COLB Unlock Forecast - 30 Days FREE Trial $5478M 10,4x 1,0x
COSO Unlock Forecast - 30 Days FREE Trial $238M x 1,1x
CPF Unlock Forecast - 30 Days FREE Trial $839M 13,8x 1,5x
CSBB Unlock Forecast - 30 Days FREE Trial $120M 9,4x 1,0x
CTBI Unlock Forecast - 30 Days FREE Trial $1030M 11,3x 1,3x
CUBB Unlock Forecast - 30 Days FREE Trial $693M 4,7x 0,4x
CUBI Unlock Forecast - 30 Days FREE Trial $2201M 14,9x 1,2x
CUBI-PF Unlock Forecast - 30 Days FREE Trial $815M 5,5x 0,4x
CVBF Unlock Forecast - 30 Days FREE Trial $2772M 13,6x 1,2x
CWBC Unlock Forecast - 30 Days FREE Trial $406M 15,4x 1,1x
CZFS Unlock Forecast - 30 Days FREE Trial $295M 9,3x 0,9x
CZNC Unlock Forecast - 30 Days FREE Trial $313M 11,6x 1,1x
EBMT Unlock Forecast - 30 Days FREE Trial $140M 11,1x 0,8x
EBTC Unlock Forecast - 30 Days FREE Trial $496M 14,6x 1,3x
EFSC Unlock Forecast - 30 Days FREE Trial $2253M 11,2x 1,2x
EFSCP Unlock Forecast - 30 Days FREE Trial $771M 3,8x 0,4x
EFSI Unlock Forecast - 30 Days FREE Trial $201M 25,4x 1,1x
EGBN Unlock Forecast - 30 Days FREE Trial $602M -22,5x 0,5x
EMYB Unlock Forecast - 30 Days FREE Trial $133M 11,4x 1,2x
EQBK Unlock Forecast - 30 Days FREE Trial $735M 10,9x 1,2x
EWBC Unlock Forecast - 30 Days FREE Trial $15210M 12,8x 1,9x
FBIZ Unlock Forecast - 30 Days FREE Trial $433M 9,1x 1,3x
FBK Unlock Forecast - 30 Days FREE Trial $2470M 27,3x 1,5x
FBNC Unlock Forecast - 30 Days FREE Trial $2289M 23,6x 1,5x
FBP Unlock Forecast - 30 Days FREE Trial $3539M 11,5x 1,9x
FCBC Unlock Forecast - 30 Days FREE Trial $686M 13,7x 1,4x
FCCO Unlock Forecast - 30 Days FREE Trial $215M 12,4x 1,4x
FCNCA Unlock Forecast - 30 Days FREE Trial $26473M 11,0x 1,2x
FCNCB Unlock Forecast - 30 Days FREE Trial $22320M 9,3x 1,0x
FCNCO Unlock Forecast - 30 Days FREE Trial $307M 0,1x 0,0x
FCNCP Unlock Forecast - 30 Days FREE Trial $294M 0,1x 0,0x
FFIC Unlock Forecast - 30 Days FREE Trial $457M 19,5x 0,7x
FFIN Unlock Forecast - 30 Days FREE Trial $5165M 21,0x 3,0x
FFNW Unlock Forecast - 30 Days FREE Trial $208M 81,8x 1,3x
FFWM Unlock Forecast - 30 Days FREE Trial $494M -23,9x 0,5x
FHB Unlock Forecast - 30 Days FREE Trial $3234M 13,1x 1,2x
FIBK Unlock Forecast - 30 Days FREE Trial $3427M 14,9x 1,0x
FINW Unlock Forecast - 30 Days FREE Trial $261M 19,3x 1,4x
FITB Unlock Forecast - 30 Days FREE Trial $30721M 13,2x 1,5x
FITBI Unlock Forecast - 30 Days FREE Trial $17315M 7,4x 0,8x
FITBO Unlock Forecast - 30 Days FREE Trial $13960M 6,0x 0,7x
FITBP Unlock Forecast - 30 Days FREE Trial $16748M 7,2x 0,8x
FKYS Unlock Forecast - 30 Days FREE Trial $107M 13,8x 1,0x
FMBH Unlock Forecast - 30 Days FREE Trial $962M 11,4x 1,1x
FMBM Unlock Forecast - 30 Days FREE Trial $87M 10,3x 0,9x
FMNB Unlock Forecast - 30 Days FREE Trial $567M 11,2x 1,3x
FRAF Unlock Forecast - 30 Days FREE Trial $211M 14,5x 1,3x
FRST Unlock Forecast - 30 Days FREE Trial $294M -22,0x 0,8x
FSBC Unlock Forecast - 30 Days FREE Trial $701M 13,5x 1,7x
FUSB Unlock Forecast - 30 Days FREE Trial $76M 9,8x 0,7x
FVCB Unlock Forecast - 30 Days FREE Trial $227M 12,0x 0,9x
FXNC Unlock Forecast - 30 Days FREE Trial $212M 26,6x 1,2x
GABC Unlock Forecast - 30 Days FREE Trial $1534M 17,8x 1,4x
GBCI Unlock Forecast - 30 Days FREE Trial $5799M 26,3x 1,6x
GBFH Unlock Forecast - 30 Days FREE Trial $582M x 3,8x
GLBZ Unlock Forecast - 30 Days FREE Trial $16M 28,2x 0,8x
GNRV Unlock Forecast - 30 Days FREE Trial $7M x 0,7x
GSBC Unlock Forecast - 30 Days FREE Trial $724M 10,6x 1,2x
HBIA Unlock Forecast - 30 Days FREE Trial $747M 13,3x 1,5x
HBNC Unlock Forecast - 30 Days FREE Trial $715M 13,8x 0,9x
HBT Unlock Forecast - 30 Days FREE Trial $808M 10,5x 1,4x
HMST Unlock Forecast - 30 Days FREE Trial $262M -13,1x 0,7x
HNVR Unlock Forecast - 30 Days FREE Trial $166M 14,6x 0,8x
HOMB Unlock Forecast - 30 Days FREE Trial $5923M 15,8x 1,5x
HONE Unlock Forecast - 30 Days FREE Trial $559M 21,2x 1,0x
HTBK Unlock Forecast - 30 Days FREE Trial $635M 16,2x 0,9x
HTH Unlock Forecast - 30 Days FREE Trial $2250M 15,7x 1,0x
HTLF Unlock Forecast - 30 Days FREE Trial $0M 33,6x 0,0x
HTLFP Unlock Forecast - 30 Days FREE Trial $0M 12,6x 0,0x
HWC Unlock Forecast - 30 Days FREE Trial $5450M 13,1x 1,3x
HWCPZ Unlock Forecast - 30 Days FREE Trial $2067M 5,5x 0,5x
IBCP Unlock Forecast - 30 Days FREE Trial $1380M 21,3x 2,9x
IBOC Unlock Forecast - 30 Days FREE Trial $4396M 10,7x 1,5x
IBTX Unlock Forecast - 30 Days FREE Trial $2514M -8,0x 1,3x
INBK Unlock Forecast - 30 Days FREE Trial $215M 13,9x 0,6x
INBKZ Unlock Forecast - 30 Days FREE Trial $218M 14,1x 0,6x
INDB Unlock Forecast - 30 Days FREE Trial $3038M 16,1x 1,0x
ISBA Unlock Forecast - 30 Days FREE Trial $239M 14,7x 1,1x
ISTR Unlock Forecast - 30 Days FREE Trial $230M 10,3x 0,9x
JMSB Unlock Forecast - 30 Days FREE Trial $288M 15,2x 1,1x
LKFN Unlock Forecast - 30 Days FREE Trial $1677M 17,7x 2,4x
LNKB Unlock Forecast - 30 Days FREE Trial $274M 71,1x 1,0x
LOB Unlock Forecast - 30 Days FREE Trial $1681M 30,0x 1,6x
MBCN Unlock Forecast - 30 Days FREE Trial $246M 13,5x 1,1x
MBIN Unlock Forecast - 30 Days FREE Trial $1491M 5,9x 0,7x
MBINL Unlock Forecast - 30 Days FREE Trial $1070M 4,2x 0,5x
MBINM Unlock Forecast - 30 Days FREE Trial $1166M 4,6x 0,5x
MBINN Unlock Forecast - 30 Days FREE Trial $945M 3,7x 0,4x
MBINO Unlock Forecast - 30 Days FREE Trial $1144M 4,0x 0,6x
MBWM Unlock Forecast - 30 Days FREE Trial $775M 9,5x 1,2x
MCB Unlock Forecast - 30 Days FREE Trial $850M 12,4x 1,2x
MCBS Unlock Forecast - 30 Days FREE Trial $745M 11,3x 1,7x
MNSB Unlock Forecast - 30 Days FREE Trial $170M 11,1x 0,8x
MNSBP Unlock Forecast - 30 Days FREE Trial $183M 13,3x 0,9x
MOFG Unlock Forecast - 30 Days FREE Trial $622M -84,8x 1,1x
MPB Unlock Forecast - 30 Days FREE Trial $693M 15,7x 0,9x
MSBI Unlock Forecast - 30 Days FREE Trial $394M 7,4x 0,5x
MSBIP Unlock Forecast - 30 Days FREE Trial $514M 9,7x 0,6x
MTB Unlock Forecast - 30 Days FREE Trial $32307M 12,0x 1,1x
MTB-PH Unlock Forecast - 30 Days FREE Trial $4029M 1,5x 0,1x
MTB-PJ Unlock Forecast - 30 Days FREE Trial $4375M 1,6x 0,2x
MVBF Unlock Forecast - 30 Days FREE Trial $316M 18,5x 1,1x
MYFW Unlock Forecast - 30 Days FREE Trial $226M 19,6x 0,9x
NPB Unlock Forecast - 30 Days FREE Trial $641M x 1,1x
NTRS Unlock Forecast - 30 Days FREE Trial $25204M 14,5x 2,0x
NTRSO Unlock Forecast - 30 Days FREE Trial $4014M 2,3x 0,3x
NWFL Unlock Forecast - 30 Days FREE Trial $247M 77,9x 1,1x
NWPP Unlock Forecast - 30 Days FREE Trial $75M 8,2x 1,0x
OBK Unlock Forecast - 30 Days FREE Trial $1111M 15,9x 0,9x
OBT Unlock Forecast - 30 Days FREE Trial $357M 12,1x 1,4x
OFG Unlock Forecast - 30 Days FREE Trial $1981M 10,2x 1,5x
OPBK Unlock Forecast - 30 Days FREE Trial $212M 9,5x 1,0x
ORRF Unlock Forecast - 30 Days FREE Trial $683M 15,8x 1,3x
OSBC Unlock Forecast - 30 Days FREE Trial $842M 10,1x 1,2x
OVBC Unlock Forecast - 30 Days FREE Trial $0M 7,7x 0,0x
OVLY Unlock Forecast - 30 Days FREE Trial $245M 10,1x 1,3x
PB Unlock Forecast - 30 Days FREE Trial $6464M 12,4x 0,9x
PBHC Unlock Forecast - 30 Days FREE Trial $84M 12,4x 0,7x
PCB Unlock Forecast - 30 Days FREE Trial $313M 9,9x 0,8x
PEBK Unlock Forecast - 30 Days FREE Trial $173M 10,2x 1,2x
PEBO Unlock Forecast - 30 Days FREE Trial $1072M 10,3x 0,9x
PFBX Unlock Forecast - 30 Days FREE Trial $92M 4,7x 1,0x
PFC Unlock Forecast - 30 Days FREE Trial $1038M 13,2x 1,0x
PKBK Unlock Forecast - 30 Days FREE Trial $270M 8,7x 0,9x
PMHG Unlock Forecast - 30 Days FREE Trial $171M 21,0x 1,9x
PPBI Unlock Forecast - 30 Days FREE Trial $2376M 17,2x 0,8x
PWOD Unlock Forecast - 30 Days FREE Trial $244M 14,7x 1,5x
QCRH Unlock Forecast - 30 Days FREE Trial $1306M 11,6x 1,2x
QNBC Unlock Forecast - 30 Days FREE Trial $132M 10,3x 1,2x
RBB Unlock Forecast - 30 Days FREE Trial $354M 15,4x 0,7x
RBCAA Unlock Forecast - 30 Days FREE Trial $1501M 12,1x 1,4x
RMBI Unlock Forecast - 30 Days FREE Trial $153M 16,1x 1,2x
RNST Unlock Forecast - 30 Days FREE Trial $3679M 23,0x 1,0x
RRBI Unlock Forecast - 30 Days FREE Trial $427M 13,0x 1,3x
RVRF Unlock Forecast - 30 Days FREE Trial $272M 7,1x 1,1x
SBCF Unlock Forecast - 30 Days FREE Trial $2654M 19,1x 1,2x
SBFG Unlock Forecast - 30 Days FREE Trial $8M 10,8x 0,1x
SBSI Unlock Forecast - 30 Days FREE Trial $937M 10,9x 1,2x
SFBS Unlock Forecast - 30 Days FREE Trial $4576M 18,3x 2,7x
SFDL Unlock Forecast - 30 Days FREE Trial $98M 8,4x 0,5x
SLBK Unlock Forecast - 30 Days FREE Trial $101M 9,3x 1,0x
SPFI Unlock Forecast - 30 Days FREE Trial $687M 12,6x 1,5x
SRCE Unlock Forecast - 30 Days FREE Trial $1631M 11,6x 1,4x
SSB Unlock Forecast - 30 Days FREE Trial $10311M 17,4x 1,2x
SSBK Unlock Forecast - 30 Days FREE Trial $361M 10,6x 1,2x
STBA Unlock Forecast - 30 Days FREE Trial $1499M 12,4x 1,1x
STT Unlock Forecast - 30 Days FREE Trial $32787M 11,5x 1,2x
STT-PG Unlock Forecast - 30 Days FREE Trial $6765M 2,4x 0,3x
SYBT Unlock Forecast - 30 Days FREE Trial $2268M 17,7x 2,3x
TCBI Unlock Forecast - 30 Days FREE Trial $4036M 30,1x 1,2x
TCBIO Unlock Forecast - 30 Days FREE Trial $954M 7,1x 0,3x
TCBK Unlock Forecast - 30 Days FREE Trial $1500M 13,4x 1,2x
TECTP Unlock Forecast - 30 Days FREE Trial $74M 4,5x 0,6x
TFIN Unlock Forecast - 30 Days FREE Trial $1399M 102,7x 1,5x
TFINP Unlock Forecast - 30 Days FREE Trial $522M 38,3x 0,6x
THFF Unlock Forecast - 30 Days FREE Trial $664M 12,1x 1,2x
TMP Unlock Forecast - 30 Days FREE Trial $0M 47,6x 0,0x
TRST Unlock Forecast - 30 Days FREE Trial $752M 14,1x 1,1x
UBCP Unlock Forecast - 30 Days FREE Trial $82M 9,3x 1,4x
UBSI Unlock Forecast - 30 Days FREE Trial $5332M 13,5x 1,0x
UCB Unlock Forecast - 30 Days FREE Trial $3936M 14,4x 1,1x
UCB-PI Unlock Forecast - 30 Days FREE Trial $3033M 11,1x 0,8x
UNB Unlock Forecast - 30 Days FREE Trial $0M 16,5x 0,0x
UNTY Unlock Forecast - 30 Days FREE Trial $534M 10,6x 1,7x
USCB Unlock Forecast - 30 Days FREE Trial $0M -3,5x 0,0x
UVSP Unlock Forecast - 30 Days FREE Trial $909M 11,4x 1,0x
UWHR Unlock Forecast - 30 Days FREE Trial $84M 8,3x 1,5x
VBFC Unlock Forecast - 30 Days FREE Trial $120M 56,1x 1,6x
VBTX Unlock Forecast - 30 Days FREE Trial $3760M 32,5x 2,3x
WAL Unlock Forecast - 30 Days FREE Trial $10098M 11,9x 1,4x
WAL-PA Unlock Forecast - 30 Days FREE Trial $2587M 3,1x 0,4x
WASH Unlock Forecast - 30 Days FREE Trial $581M 13,8x 1,1x
WTBA Unlock Forecast - 30 Days FREE Trial $345M 11,9x 1,4x
WTFC Unlock Forecast - 30 Days FREE Trial $9183M 12,4x 1,3x
WTFCM Unlock Forecast - 30 Days FREE Trial $1807M 2,6x 0,3x
WTFCN Unlock Forecast - 30 Days FREE Trial $1811M 2,5x 0,3x
WTFCP Unlock Forecast - 30 Days FREE Trial $1814M 2,6x 0,3x

Preguntas frecuentes - 1ST SOURCE CORP Previsión de existencias

¿Hasta qué punto son precisas las predicciones bursátiles de 1ST SOURCE CORP?

Our AI model demonstrates 61% historical accuracy for SRCE predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

¿Qué factores influyen en las previsiones 1ST SOURCE CORP del precio de las acciones?

Nuestro análisis tiene en cuenta las métricas financieras de 1ST SOURCE CORP, las tendencias del sector Finance, el sentimiento del mercado, los indicadores técnicos, los datos de beneficios y los factores macroeconómicos que afectan al rendimiento de las acciones.

¿Es 1ST SOURCE CORP una buena inversión en 2025?

Según nuestro análisis de IA, 1ST SOURCE CORP muestra potencial para diversos escenarios de mercado. Considere su tolerancia al riesgo, el plazo de inversión y la diversificación de la cartera antes de tomar decisiones de inversión.

¿Con qué frecuencia se actualizan las previsiones 1ST SOURCE CORP?

Las previsiones bursátiles de 1ST SOURCE CORP se actualizan a diario utilizando datos de mercado en tiempo real, lo que garantiza que reciba las predicciones y perspectivas de inversión más actuales basadas en IA.

¿Desea un análisis 1ST SOURCE CORP más avanzado?

Desbloquee las funciones premium, incluidos los objetivos de precios detallados, las evaluaciones de riesgo, la optimización de la cartera y las alertas en tiempo real para las acciones 1ST SOURCE CORP.

🎯 Análisis Premium 📊 Más acciones

Mi cartera

Panel de inversiones

Cargando su cartera...